Εμφάνιση απλής εγγραφής

dc.creatorGalanakis, P. A.en
dc.creatorSpyroulias, G. A.en
dc.creatorRizos, A.en
dc.creatorSamolis, P.en
dc.creatorKrambovitis, E.en
dc.date.accessioned2015-11-23T10:26:52Z
dc.date.available2015-11-23T10:26:52Z
dc.date.issued2005
dc.identifier10.2174/0929867054038982
dc.identifier.issn9298673
dc.identifier.urihttp://hdl.handle.net/11615/27619
dc.description.abstractInfection of target host cells by the human immunodeficiency virus-1 (HIV-1) is a multi-step process involving a series of conformational changes in the viral gp120 and gp41 proteins. Gp120 binding to the main cell receptor, CD4, on the surface of cells expressing this molecule, and interaction with the cell chemokine receptors CCR5 and CXCR4, are among the key events for HIV-1 infection. These steps are crucial for the virus and offer potential therapeutic targets. For this reason, understanding the structure and the physicochemical characteristics of the gp120 in relation to these interactions has drawn much attention. This review article focuses on the biologically important V3 region of the gp120 and summarizes the functional role, the sequence variation and the conformational features of V3 peptides, which are important for co-receptor selectivity, specificity and interaction. Synthetic V3 peptides have been extensively studied by NMR spectroscopy and X-ray crystallography, in solution or in solid state, in their free or bound form, and valuable information was generated with the aim to be exploited in the design of new, effective inhibitors of HIV-1 infection. The features of the potential gp120 interacting sites on the two chemokine co-receptors, CCR5 and CXCR4, are also discussed, and co-receptor blocking molecules under clinical trial are also reported. © 2005 Bentham Science Publishers Ltd.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-21044452929&partnerID=40&md5=a74f1ace8e5aafdf0142a779ea74bbff
dc.subjectAIDSen
dc.subjectCCR5/CXCR4 co-receptorsen
dc.subjectHIV inhibitorsen
dc.subjectHIV-1 gp120en
dc.subjectV3 hypervariable loopen
dc.subjectX-ray crystallography and NMR spectroscopyen
dc.subject1,1' [1,4 phenylenebis(methylene)]bis(1,4,8,11 tetraazacyclotetradecane)en
dc.subject4,4' [carbonylbis[imino 1h pyrrole 4,2 diylcarbonylimino(1 methyl 1h pyrrole 4,2 diyl)carbonylimino]]bis(1,7 naphthalenesulfonic acid)en
dc.subjectalpha n acetylnona dextro arginine amideen
dc.subjectalx 40en
dc.subjectantivirus agenten
dc.subjectCD4 antigenen
dc.subjectCD4 immunoglobulin G2en
dc.subjectcell receptoren
dc.subjectchemokine receptor CCR5en
dc.subjectchemokine receptor CXCR4en
dc.subjectenfuvirtideen
dc.subjectglycoprotein gp 120en
dc.subjectglycoprotein gp 41en
dc.subjectmaravirocen
dc.subjectn [4 [[[6,7 dihydro 2 (4 methylphenyl) 5h benzocyclohepten 8 yl]carbonyl]amino]benzyl] n,n dimethyl 2h tetrahydropyran 4 aminium chlorideen
dc.subjectt 1249en
dc.subjectt 22en
dc.subjectTNX 355en
dc.subjectunclassified drugen
dc.subjectvirus proteinen
dc.subjectamino acid sequenceen
dc.subjectcell surfaceen
dc.subjectcellular distributionen
dc.subjectclinical trialen
dc.subjectdrug safetyen
dc.subjectdrug targetingen
dc.subjecthumanen
dc.subjectHuman immunodeficiency virus 1en
dc.subjectHuman immunodeficiency virus infectionen
dc.subjectimmunogeneticsen
dc.subjectnonhumanen
dc.subjectnuclear magnetic resonance spectroscopyen
dc.subjectprotein bindingen
dc.subjectprotein conformationen
dc.subjectprotein domainen
dc.subjectprotein functionen
dc.subjectprotein localizationen
dc.subjectprotein motifen
dc.subjectprotein protein interactionen
dc.subjectprotein structureen
dc.subjectreviewen
dc.subjectsolid stateen
dc.subjectstructure analysisen
dc.subjectX ray crystallographyen
dc.subjectAnti-HIV Agentsen
dc.subjectChemokinesen
dc.subjectCrystallography, X-Rayen
dc.subjectHIV Envelope Protein gp120en
dc.subjectHIV Envelope Protein gp41en
dc.subjectHIV Infectionsen
dc.subjectHIV-1en
dc.subjectHumansen
dc.subjectMagnetic Resonance Spectroscopyen
dc.subjectReceptors, CCR5en
dc.subjectReceptors, CXCR4en
dc.titleConformational properties of HIV-1 gp120/V3 immunogenic domainsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής